Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meta-Risk Hepatectomy
NL-OMON61464Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- Sep 2026
- Countries
- 1
01
Overview
Open-label trial in type 2 diabetes mellitus (T2DM) and obesity (2 cohorts), sponsored by Erasmus MC. Primary endpoint: Post-hepatectomy liver failure. Planned start Sep 2026; status: not yet recruiting.
02
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on NL-OMON61464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON61464.